Institutional investors purchased a net $206.4 thousand shares of ABIO during the quarter ended March 2014. This may signal that the smart money is gaining interest in this company as the 4.81% of shares outstanding that institutional investors hold is actually below the Biotechnology industry average.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
GRT CAPITAL PARTNERS LLC Bought 210.6 Thousand shares of ARCA Biopharma Inc
THE CALIFORNIA PUBLIC EMPLOYEES ... Bought 57.7 Thousand shares of ARCA Biopharma Inc